Inventor · disambiguated record
Matthew Patricelli
Also filed as: PATRICELLI MATTHEW · PATRICELLI MATTHEW P · PATRICELLI MATTHEW PETER
8 granted patents·11 pending applications·192 citations·filing 2000–2023
86Inventor score
Files withVIVIDION THERAPEUTICS INC9ARAXES PHARMA LLC4ACTIVX BIOSCIENCES INC2CRAVATT BENJAMIN F2SCRIPPS RESEARCH INST1
Top patents by PatentIndex Score
19 records- 0198US9810690B2Method for screening inhibitors of RasARAXES PHARMA LLC·Filed 2016·Granted Nov 7, 2017·41 cites·30 claims
- 0295US10111874B2Combination therapies for treatment of cancerARAXES PHARMA LLC·Filed 2015·Granted Oct 30, 2018·39 cites·20 claims
- 0390US6872574B2Proteomic analysisSCRIPPS RESEARCH INST·Filed 2001·Granted Mar 29, 2005·78 cites·5 claims
- 0482US7179655B2Protein profiling platformACTIVX BIOSCIENCES INC·Filed 2002·Granted Feb 20, 2007·32 cites·39 claims
- 0577US10781239B2In vivo engineered cereblon proteinVIVIDION THERAPEUTICS INC·Filed 2019·Granted Sep 22, 2020·1 cites·24 claims
- 0673US10869860B2Cereblon modulators and uses thereofVIVIDION THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·1 cites·30 claims
- 0766US2022298213A1In vivo engineered cereblon proteinVIVIDION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0861US2024226114A1Inhibitors and uses thereofVIVIDION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0959US2024270705A1Compounds selective for jak1 and methods of useVIVIDION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1059US2018246102A1Method for screening inhibitors of rasARAXES PHARMA LLC·Filed 2017·Application pending·0 cites
- 1158US2002182652A1Proteomic analysisCRAVATT BENJAMIN F·Filed 2002·Application pending·0 cites
- 1258US2021002337A1In vivo engineered cereblon proteinVIVIDION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1357US11771689B2Cereblon modulators and uses thereofVIVIDION THERAPEUTICS INC·Filed 2020·Granted Oct 3, 2023·0 cites·20 claims
- 1454US2002045194A1Proteomic analysisFiled 2000·Application pending·0 cites
- 1554US2005287594A1Proteomic analysisCRAVATT BENJAMIN F·Filed 2000·Application pending·0 cites
- 1651US2024123078A1Compounds and methods for modulating immune-related proteinsVIVIDION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1750US2019262342A1Combination therapies for treatment of cancerARAXES PHARMA LLC·Filed 2018·Application pending·0 cites
- 1840US2020239530A1Compounds and methods of modulating protein degradationVIVIDION THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1939US7083987B2Activity based probe analysisACTIVX BIOSCIENCES INC·Filed 2002·Granted Aug 1, 2006·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Matthew Patricelli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →